Innovent Announces IBI363 (PD-1/IL-2Α-Bias Bispecific Fusion Protein) Received Third NMPA Breakthrough Therapy Designation For MSS/Pmmr Metastatic Colorectal Cancer
english top health
(MENAFN - PR Newswire) SAN FRANCISCO and SUZHOU, China, May 10, 2026 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, ... 2026-05-10 20:11:57
Акыркы Кабарлар жана Баш макалалар
(MENAFN - PR Newswire) SAN FRANCISCO and SUZHOU, China, May 10, 2026 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a wo...
Жаңылыктар